Kathleen Swanson

Associate

Overview

Kathleen Swanson is an associate in the firm’s Health Care Group. She focuses her practice on managed care matters, advising clients on a wide range of regulatory issues.

Prior to joining Crowell & Moring, Kathleen served as an attorney-advisor for the U.S. Department of Health and Human Services’ Office of the General Counsel. In this capacity, she advised Centers for Medicare and Medicaid Services teams on matters involving the Inflation Reduction Act (IRA), the Medicare Drug Price Negotiation Program, HIPAA, and data privacy, among other issues.

During law school at the University of Maryland, Kathleen received the CALI Excellence for the Future Award for Torts and Criminal Law. She also served as co-president of the Student Health Law Organization and as notes and comments editor of the Journal of Health Care Law and Policy.

Career & Education

    • University of Maryland School of Law, J.D.,
      cum laude
      , 2020
    • The Ohio State University, B.A., political science, magna cum laude, 2017
    • University of Maryland School of Law, J.D.,
      cum laude
      , 2020
    • The Ohio State University, B.A., political science, magna cum laude, 2017
    • District of Columbia
    • District of Columbia

Kathleen's Insights

Client Alert | 2 min read | 02.03.26

CMS Doubles Down on RADV Audit Changes

On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) released a Health Plan Management System (HPMS) memo that provided a long-awaited update on how the agency plans to approach previously announced Risk Adjustment Data Validation (RADV) audits for Payment Years (PY) 2020-2024. The memo is the agency’s most comprehensive statement on the subject since September 25, 2025, when the Northern District of Texas vacated the 2023 RADV Final Rule. The memo makes clear that, while CMS has made certain operational adjustments in response to concerns expressed by Medicare Advantage Organizations (MAOs), the agency is largely pressing forward with the accelerated audit strategy announced in May 2025....

Kathleen's Insights

Client Alert | 2 min read | 02.03.26

CMS Doubles Down on RADV Audit Changes

On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) released a Health Plan Management System (HPMS) memo that provided a long-awaited update on how the agency plans to approach previously announced Risk Adjustment Data Validation (RADV) audits for Payment Years (PY) 2020-2024. The memo is the agency’s most comprehensive statement on the subject since September 25, 2025, when the Northern District of Texas vacated the 2023 RADV Final Rule. The memo makes clear that, while CMS has made certain operational adjustments in response to concerns expressed by Medicare Advantage Organizations (MAOs), the agency is largely pressing forward with the accelerated audit strategy announced in May 2025....